Gulbany Sarsenbaeva
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 26, 2025
Pharmaco-Technological Characterization, Structural Analysis, and Toxicological Evaluation of the Novel Polyene Antibiotic Roseofungin for Drug Development.Amankeldy Sadanov, Dmitriy Berillo, Assya Bagimbayeva
|Apr 28, 2023
Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.Anna-Polina Shurygina, Natalia Zabolotnykh, Tatiana Vinogradova
|Feb 13, 2020
Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.Gulbanu Sarsenbayeva, Timur Issagulov, Markhabat Kassenov
|Nov 08, 2017
Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.Gulbanu Sarsenbayeva, Yevgeniy Volgin, Markhabat Kassenov
|Aug 27, 2017
Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial.Gulbanu Sarsenbayeva, Yevgeniy Volgin, Markhabat Kassenov
|Feb 05, 2017
A novel preservative-free seasonal influenza vaccine safety and immune response study in the frame of preclinical research.Gulbanu Sarsenbayeva, Yevgeniy Volgin, Markhabat Kassenov
Pageof 1
